Enliven Therapeutics Inc
XNAS: ELVN
Enliven Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product...
Read More
18.30
-0.20
(-1.08%)
522.8K
XNAS Volume
XNAS 06 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for Enliven Therapeutics Inc is on 13 Nov 2025 for the purpose of Enliven Therapeutics Inc Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Enliven Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..